Michael Ambrogi
2019
In 2019, Michael Ambrogi earned a total compensation of $4.7M as Chief Operating Officer at NovoCure, a 79% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $257,400 |
---|---|
Option Awards | $3,245,466 |
Salary | $390,000 |
Stock Awards | $769,998 |
Other | $13,400 |
Total | $4,676,264 |
Ambrogi received $3.2M in option awards, accounting for 69% of the total pay in 2019.
Ambrogi also received $257.4K in non-equity incentive plan, $390K in salary, $770K in stock awards and $13.4K in other compensation.
Rankings
In 2019, Michael Ambrogi's compensation ranked 2,412th out of 13,971 executives tracked by ExecPay. In other words, Ambrogi earned more than 82.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,412 out of 13,971 | 83rd |
Division Manufacturing | 872 out of 5,701 | 85th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 115 out of 832 | 86th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 60 out of 535 | 89th |
Industry Surgical and Medical Instruments and Apparatus | 37 out of 350 | 89th |
Source: SEC filing on April 27, 2020.
Ambrogi's colleagues
We found four more compensation records of executives who worked with Michael Ambrogi at NovoCure in 2019.